Thyroid disease and increased cardiovascular risk

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Epidemiology

Background:

• Thyroid dysfunction effects are typically reversible upon euthyroidism.
• However, data suggest subclinical or treated thyroid disease correlates with elevated vascular risk.
• The specific nature and treatment of thyroid disease's impact on vascular risk require further investigation.

Purpose of the Study:

• To determine the extent of vascular risk associated with treated thyroid disease.
• To explore if the type and treatment of thyroid disease influence this vascular risk.
• To compare cardiovascular and cerebrovascular disease hospitalizations and mortality in thyroid disease patients versus controls.

Main Methods:

• Utilized medical record linkage to match patients with treated thyroid disease to national hospital discharge and death records.
• Assessed hospitalizations for cardiovascular or cerebrovascular disease and death.
• Compared outcomes between patients with various thyroid disease etiologies and control groups.

Main Results:

• Graves' disease patients showed a 1.42-fold increased risk of cardiovascular hospitalizations (p < 0.001).
• Toxic multinodular goiter was associated with a 1.50-fold increased risk of cardiovascular disease (p = 0.008).
• Hashimoto's thyroiditis patients over 50 had a threefold increase in cardiovascular admissions compared to controls (23.5% vs. 6.5%, p = 0.003).

Conclusions:

• Different forms of treated thyroid disease are linked to increased long-term vascular risk, even after achieving euthyroidism.
• The underlying mechanisms for this persistent vascular risk are not fully understood.
• These mechanisms may not be solely dependent on thyroid hormone levels.